Prescription Audits: When the DEA or AG Come Knocking
Anticipating and Responding to Heightened Investigations of Prescribing and Dispensing Practices
Recording of a 90-minute CLE webinar with Q&A
This CLE webinar will discuss the increased scrutiny of healthcare providers’ prescribing and dispensing practices by the Drug Enforcement Administration (DEA) and state attorneys general (AG) through their medical boards and other actions, and will guide counsel in preparing for and responding to prescription audits and ensuring ongoing regulatory compliance.
- Current trends in prescribing and dispensing enforcement
- Audit process
- State AG
- Audit preparedness
- Maintaining records
- Policies and procedures
- Risk issues
- Responding to an audit
The panel will review these and other key issues:
- What should providers and counsel expect when the DEA or state AG conducts a prescription audit?
- What policies and procedures should be in place to ensure compliance with federal regulations?
- What best practices should counsel and providers employ when facing a DEA or state AG audit?
Ronald J. Friedman
Karr Tuttle Campbell
Mr. Friedman’s practice focuses on regulatory compliance, white collar criminal defense, pharmacy... | Read More
Mr. Friedman’s practice focuses on regulatory compliance, white collar criminal defense, pharmacy law, complex litigation, and professional license defense. He entered private practice after serving 22 years as a federal prosecutor with the U.S. Department of Justice. Mr. Friedman has extensive experience in pharmaceutical compliance and licensing, DEA and FDA regulatory compliance, FCPA compliance, and providing a defense and guidance in all matters which may arise under the federal criminal laws. He is a frequent author and lecturer on prescription regulations and compliance, among other topics.Close
Lee H. Rosebush
A registered patent attorney and registered pharmacist, Mr. Rosebush focuses his practice on FDA, regulatory,... | Read More
A registered patent attorney and registered pharmacist, Mr. Rosebush focuses his practice on FDA, regulatory, compliance and enforcement issues pertaining to pharmaceuticals, biologics and medical devices. He assists clients with healthcare-related issues stemming from Medicare, Medicaid and state regulatory requirements. He advises clients in matters relating to FDA regulatory compliance, including governance in the drug naming process, clinical trial, marketing, promotion and advertisement and approval process.Close